XeroThera has developed breakthrough technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules. The technology is the result of twenty years of fundamental studies on sol gel processed, nanoporous, oxide-based materials in academic laboratories at the University of Pennsylvania, Philadelphia.
XeroThera’s unique delivery concepts make it possible to treat conditions that currently defy solutions. It has formulated a pipeline of product concepts that address the prevention and treatment of surgical infections, bone infections, and resistant (“MRSA”) infection; it can also develop tissue engineering scaffolds, and address surgical pain treatment and diabetes wound treatment.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 175 Strafford Ave, Wayne,pennsylvania 19087,united States
- Industry
- Medical Device
- Website
- xerotherainc.com
- Keywords
- Xerogel, Synthetic Graft, Controlled Release.
- HQ
- Wayne, Pennsylvania
Xerothera Questions
Xerothera's website is xerotherainc.com
Xerothera's LinkedIn profile is https://www.linkedin.com/company/xerotherainc
Xerothera has
4 employees.
View email and phone details for 4
employees at Xerothera.
Xerothera's industry is
Medical Device
Xerothera's top competitors are
Strand,
Mind And Market,
Avilar Therapeutics,
Theratrame,
Xerothera Europe,
Receptor.ai,
Observatoire De La Recherche Et Des Carrières Scientifiques - F.r.s.-Fnrs,
Nanochon,
Diasource Immunoassays,
Keystone.
Xerothera's categories are Medical Device
Xerothera's founding year is 2014
